EUVIMEDEUVIMED entdecken
Crossref

Exosomal Lnc-DLK1-35 reprograms microglia into a pro-tumorigenic phenotype via a non-canonical cytokine signature to promote glioblastoma progression and chemoresistance

Dan Li, Yufeng Li, Zhuo Wang, Xuan Zheng, Yang Wang, Jianxiong Guo, Jingwu Li, Yongliang Liu, Yuhui Li

Folia Histochem Cytobiol. · 11.03.2026

DOI: 10.5603/fhc.109684 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Histochem Cytobiol., online erschienen am 11.03.2026. Verfasst von Dan Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Key Laboratory of Molecular Oncology, Tangshan People's Hospital, Hebei, China. Hauptthemen laut MEDLINE: Microglia, Exosomes, Glioblastoma, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaExosomesGlioblastomaDrug Resistance, NeoplasmCytokinesRNA, Long NoncodingBrain NeoplasmsHumansTemozolomideCell Line, TumorPhenotypeDisease Progression

Stichwörter der Autor:innen

exosomesglioblastomamicroglial cellsmicroglial polarizationtemozolomide

Substanzen

CytokinesTemozolomideRNA, Long Noncoding

Autor:innen und Institutionen

  • Hebei Key Laboratory of Molecular Oncology, Tangshan People's Hospital, Hebei, China.
  • Tangshan Key Laboratory of Cancer Prevention and Therapy, Tangshan People's Hospital, Hebei, China.
  • The Cancer Institute, Tangshan People's Hospital, Hebei, China.
  • Hebei Key Laboratory of Molecular Oncology, Tangshan People's Hospital, Hebei, China. kvkntgmwxbkt@163.com.
  • Tangshan Key Laboratory of Cancer Prevention and Therapy, Tangshan People's Hospital, Hebei, China. kvkntgmwxbkt@163.com.
  • The Cancer Institute, Tangshan People's Hospital, Hebei, China. kvkntgmwxbkt@163.com.

Zitieren

APA

Li, D., Li, Y., Wang, Z., Zheng, X., Wang, Y., Guo, J., Li, J., Liu, Y., & Li, Y. (2026). Exosomal Lnc-DLK1-35 reprograms microglia into a pro-tumorigenic phenotype via a non-canonical cytokine signature to promote glioblastoma progression and chemoresistance. Folia Histochem Cytobiol.. https://doi.org/10.5603/fhc.109684

Vancouver

Li D, Li Y, Wang Z, Zheng X, Wang Y, Guo J, et al. Exosomal Lnc-DLK1-35 reprograms microglia into a pro-tumorigenic phenotype via a non-canonical cytokine signature to promote glioblastoma progression and chemoresistance. Folia Histochem Cytobiol.. 2026. doi:10.5603/fhc.109684

BibTeX
@article{Li2026,
  author = {Li, Dan and Li, Yufeng and Wang, Zhuo and Zheng, Xuan and Wang, Yang and Guo, Jianxiong and Li, Jingwu and Liu, Yongliang and Li, Yuhui},
  title = {Exosomal Lnc-DLK1-35 reprograms microglia into a pro-tumorigenic phenotype via a non-canonical cytokine signature to promote glioblastoma progression and chemoresistance},
  journal = {Folia Histochem Cytobiol.},
  year = {2026},
  doi = {10.5603/fhc.109684}
}
Kostenlos starten →